Ashley is a Vice President at PharmaVentures and has worked directly for a number of Pharmaceutical companies, undertaking both Project Execution and Business Development activities. Most notably, she has worked for firms such as Lundbeck, Teva and Glenmark, where she led business development and sales activities across a wide range of products and services.
Most recently, Ashley worked with SmartAnalyst, Inc., as the Senior Director, European Business Development supporting Global Pharmaceutical and Biotech clients in their disease, asset and portfolio strategy development. Previously, Ashley was Head of Global Business Development for the Prescient Healthcare Group, with a strong focus on Competitive Intelligence and Business Analytics. Ashley has supported decision making in the majority of the top 20 Pharma companies and many Biotechs. Ashley started her career as a Medical Representative and has held a variety of commercial and licensing roles across the Pharmaceutical and Generics sectors.
Ashley received a BSc. (Hons). in Neuroscience from the University of Glasgow and a Masters in Pharmaceutical Analysis from the University of Strathclyde.